Heart Failure

"Heart Failure" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Descriptor ID	D006333
MeSH Number(s)	C14.280.434
Concept/Terms	Heart Failure Heart Failure Cardiac Failure Heart Decompensation Heart Decompensation Decompensation, Heart Heart Failure, Right-Sided Heart Failure, Right-Sided Heart Failure, Right Sided Right-Sided Heart Failure Right Sided Heart Failure Myocardial Failure Myocardial Failure Congestive Heart Failure Congestive Heart Failure Heart Failure, Congestive Heart Failure, Left-Sided Heart Failure, Left-Sided Heart Failure, Left Sided Left-Sided Heart Failure Left Sided Heart Failure

Below are MeSH descriptors whose meaning is more general than "Heart Failure".

Diseases [C]
Cardiovascular Diseases [C14]
Heart Diseases [C14.280]
Heart Failure [C14.280.434]

Below are MeSH descriptors whose meaning is more specific than "Heart Failure".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Heart Failure" by people in this website by year, and whether "Heart Failure" was a major or minor topic of these publications.

Bar chart showing 191 publications over 24 distinct years, with a maximum of 17 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	0	1	1
1999	1	0	1
2002	4	0	4
2003	1	0	1
2004	2	1	3
2005	1	2	3
2006	3	0	3
2007	8	1	9
2008	6	1	7
2009	5	5	10
2010	7	2	9
2011	8	3	11
2012	7	0	7
2013	13	4	17
2014	6	1	7
2015	11	1	12
2016	12	1	13
2017	9	1	10
2018	9	1	10
2019	8	2	10
2020	8	3	11
2021	9	1	10
2022	14	0	14
2023	8	0	8

Below are the most recent publications written about "Heart Failure" by people in Profiles.

Segan L, Chieng D, Sugumar H, Voskoboinik A, Ling LH, Costello B, Azzopardi S, Nderitu Z, Parameswaran R, Amerena J, McLellan AJ, Lee G, Morton J, Joseph S, Wong M, Taylor A, Kalman JM, Kistler PM, Prabhu S. The impact of age on ablation outcomes in AF-mediated cardiomyopathy. J Cardiovasc Electrophysiol. 2023 10; 34(10):2065-2075.

View in: PubMed
Lala A, Onwuanyi A, Morris AA, Mentz RJ. The Launch of the Association of Black Cardiologists (ABC)-JCF Mentorship Program in Academic Writing. J Card Fail. 2023 08; 29(8):1111-1112.

View in: PubMed
Lopez-Candales A, Asif T, Sawalha K, Norgard NB. Heart Failure with Preserved Left Ventricular Ejection Fraction: A Complex Conundrum Simply Not Limited to Diastolic Dysfunction. Cardiovasc Ther. 2023; 2023:1552826.

View in: PubMed
Taylor AJ, Warren J. Diastolic Function and Fibrosis Burden: Improving Prognostication in Heart?Failure. JACC Cardiovasc Imaging. 2023 06; 16(6):797-799.

View in: PubMed
Matanes F, Siddiqui M, Velasco A, Sharifov O, Kreps E, Dudenbostel T, Judd EK, Zhang B, Lloyd SG, Oparil S, Calhoun DA. Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension. J Clin Hypertens (Greenwich). 2023 05; 25(5):416-425.

View in: PubMed
Chieng D, Sugumar H, Segan L, Tan C, Vizi D, Nanayakkara S, Al-Kaisey A, Hawson J, Prabhu S, Voskoboinik A, Finch S, Morton JB, Lee G, Mariani J, La Gerche A, Taylor AJ, Howden E, Kistler PM, Kalman JM, Kaye DM, Ling LH. Atrial Fibrillation Ablation for Heart?Failure With Preserved Ejection?Fraction: A Randomized Controlled Trial. JACC Heart Fail. 2023 06; 11(6):646-658.

View in: PubMed
Lopez-Candales A, Sawalha K, Drees BM, Norgard NB. In search of mechanisms to explain the unquestionable benefit derived from sodium-glucose cotransporter-2 (SGLT-2) inhibitors use in heart failure patients. Postgrad Med. 2023 05; 135(4):323-326.

View in: PubMed
Rene C, Faustin M, Bonhomme J, Deschamps MM, Jean-Gilles M, Rosenberg R, Ibrahim M, McNairy M, Pape JW, Devieux JG. An Adapted Self-screening Tool for Peripartum Cardiomyopathy in Haiti. Crit Pathw Cardiol. 2023 03 01; 22(1):19-24.

View in: PubMed
Eraikhuemen N, Leung S, Warren SB, Lazaridis D, Smith CH, Kearson ML, Marcellus V. Effects of the Sodium-Glucose Cotransporter Inhibitors on Cardiovascular Death and All-Cause Mortality: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Clinical Trials. Am J Cardiovasc Drugs. 2023 Mar; 23(2):113-126.

View in: PubMed
Prabhudesai D, Davis J, Chen JJ, Lim E. Potentially preventable hospitalizations and super-utilization of inpatient services among patients with chronic kidney disease in Hawai'i. BMC Nephrol. 2022 12 23; 23(1):409.

View in: PubMed

People

Explore

Similar Concepts

Top Journals